Hook + thesis
On Holding (ONON) has the look of a classic growth-recovery trade: a recognizable premium running brand posting recent double-digit revenue growth and margin expansion, trading below its 52-week high but above the spring lows. The market is giving On a growth multiple - P/E ~40 and P/B ~5.8 - yet the stock is digesting gains near $38.60, offering a defined entry with limited downside to a logical support band near the low $30s.
My thesis: buy ONON around $38.50 with a clear stop at $33.00 and a target at $55.00 over the next 180 trading days. The case rests on continued top-line acceleration, further margin leverage, and ongoing institutional accumulation versus a still-manageable short-interest backdrop. This is a measured, directional swing-position that favors participation in a renewed running/athleisure cycle while strictly limiting downside risk.
What the company does and why the market should care
On Holding is a Swiss-headquartered designer and seller of performance footwear, apparel, and accessories focused on running, outdoor, all-day wear, and tennis. The company distributes globally through wholesale partners, direct online channels, and its own retail doors. On’s products sit at the premium end of the market and command healthy gross margins when demand is strong.
The market should care because On sits at the intersection of several structural and tactical drivers: a secular interest in premium running and athleisure, a product-driven brand that has taken share from larger incumbents in specialty running, and operational leverage that shows up quickly when revenue growth re-accelerates. Recent company commentary and reported results point to mid-teens YoY revenue growth and tightening profitability - the exact ingredients that can re-rate a growth stock trading at a premium multiple.
Hard numbers that matter
| Metric | Value |
|---|---|
| Current price | $38.59 |
| Market cap | $12.77B |
| P/E | 40.21 |
| P/B | 5.83 |
| 52-week range | $31.41 - $55.95 |
| Recent quarter (Q1 2026) | Revenue +14.5% YoY (26.4% FXN), EBITDA guidance raised +100 bps |
| RSI (daily) | 53.8 |
| 10-day SMA / 50-day SMA | $38.12 / $36.51 |
Key takeaway: On is not cheap on headline multiples, but the stock sits materially off the $55.95 52-week high and has recent evidence of revenue acceleration and margin improvement. Management raised full-year EBITDA guidance and reported 14.5% revenue growth in Q1 2026 (26.4% on a currency-adjusted basis) - that combination supports a re-rating if the company continues to execute.
Technical and sentiment backdrop
Technicals are constructive-to-neutral: the stock is trading just above the 10-day SMA and comfortably above the 50-day SMA, with a neutral RSI near 54. MACD shows a slight bearish histogram currently, suggesting momentum is not runaway but also not oversold. Volume patterns show retail and institutional interest - average volumes run in the 4.7M-6.1M range depending on window - and short interest has been elevated at times (settlement 05/29/2026 showing ~20.1M shares), which can amplify moves in either direction.
Valuation framing
At a market cap of $12.77B and a P/E of ~40, On commands a premium to many consumer names but trades at a discount to its high-water mark near $56. The premium multiple reflects investor willingness to pay for growth and brand momentum. If revenue growth remains in the mid-teens with margin expansion (management raised EBITDA guidance), the current multiple is defensible. Conversely, any slowdown in growth or margin compression would make the P/E look expensive quickly.
Catalysts to drive the trade
- Continued quarterly revenue beats with FX-adjusted growth similar to Q1 - incremental confirmation of the 26% FXN trend would push the stock materially higher.
- Further margin expansion or a second guidance bump - management has already tightened FY EBITDA outlook higher by 100 bps.
- Product expansion gains - momentum from running and new categories (tennis, outdoor) could accelerate wholesale and DTC revenue.
- Institutional accumulation and short squeeze potential - higher short interest raises the chance of sudden upward moves if fundamentals surprise.
- Positive comps versus legacy incumbents (Nike/Lululemon narratives) - if On continues to steal share in specialty running, investor sentiment could re-rate the name.
Trade plan (actionable)
Entry: Buy at $38.50. This entry sits just below the current print and near the short-term moving average, giving a reasonable risk-reward versus nearby support.
Stop loss: $33.00. Place a hard stop at $33.00 to limit downside - this sits below the logical support band formed in the spring and caps risk to about $5.50 per share from entry.
Target: $55.00 over long term (180 trading days). This target is aligned with a recovery toward the stock’s 52-week high and reflects roughly 43% upside from the $38.50 entry.
Horizon: long term (180 trading days). Reason: the trade leans on continued top-line momentum and margin leverage, which typically unfold over several quarters. A horizon of ~180 trading days gives time for multiple quarterly prints and re-rating events to materialize.
Position sizing and risk control
Given the stock’s premium multiple and potential for volatility (elevated short-volume days recently), size the position so that the maximum loss to the portfolio if the stop is hit is acceptable - for most retail accounts that means risking no more than 1-2% of portfolio capital on this single trade. Tight stop discipline is central to this idea.
Risks and counterarguments
- Growth disappointment: If FX-adjusted revenue growth decelerates from the Q1 cadence, the premium multiple will be hard to justify and downside to the low $30s is plausible.
- Margin pressure: Higher input costs, promotional activity, or a mis-timed inventory build could compress margins and trigger a valuation reset.
- Competitive pressure: Large incumbents (e.g., Nike) and fast-growing niche players can accelerate price competition or product copycats, limiting On’s share gains.
- Market sentiment / macro risk: A broad sell-off or rotation away from growth stocks would likely have an outsized negative effect on a mid-cap growth name with a P/E near 40.
- Short squeeze volatility: Elevated short interest can amplify downside in the event of a negative catalyst, or conversely produce sharp rallies that reverse quickly; both create execution risk.
Counterargument
One could argue that On's multiples are already pricing in a best-case scenario and that, with a P/E north of 40, the stock leaves little margin for execution error. If growth slows or margins fail to expand as expected, the stock could reprice toward the low end of its historical range near the low $30s. That is why the stop at $33.00 is non-negotiable for this trade.
What would change my mind
I would downgrade this trade if the company reports sequential deceleration in FX-adjusted revenue growth or withdraws guidance. Conversely, accelerating listed indicators - another quarter of 20%+ FX-adjusted growth, a second guidance raise, or clear signs of category expansion into tennis/outdoor that boosts sales beyond expectations - would prompt adding to the position and pushing the target higher. I would also reassess if institutional buying faded and average daily volume materially dropped, which would increase liquidity risk.
Bottom line: On Holding offers a tactical long with a defined entry, disciplined stop, and a clear upside target tied to both operational improvement and multiples normalization. Execution risk exists, but trade mechanics and a 180-trading-day horizon give time for catalysts to play out.